https://doctransparency.com/doctor/fl/stuart/robert-dermarkarian-1770675530
Medicare Enrolled

Dr. Robert Dermarkarian, M.D.

Pulmonary Disease · Stuart, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
2221 SE OCEAN BLVD, Stuart, FL 34996
7722834428
In practice since 2006 (19 years)
NPI: 1770675530 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dermarkarian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dermarkarian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dermarkarian

Dr. Robert Dermarkarian is a pulmonary disease in Stuart, FL, with 19 years in practice. Based on federal Medicare data, Dr. Dermarkarian performed 19,757 Medicare services across 7,589 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dermarkarian received a total of $97,086 from 52 pharmaceutical and/or device companies across 633 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dermarkarian is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 0% volume in FL$ $97,086 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,757
Medicare services
Top 0% in FL for pulmonary disease
7,589
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,040 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Chronic care management, first 20 min/month5,051$51$70
Office visit, established patient (30-39 min)2,722$99$140
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme2,680$0$5
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes1,510$32$47
Remote patient monitoring device, 30 days1,292$40$55
Remote patient monitoring management, 20 min/month1,062$40$57
Chronic care management, additional 20 min/month769$39$55
Inhalation treatment for airway obstruction or sputum production672$7$21
Test to determine lung volumes using gas dilution or washout664$34$55
Test to measure expiratory airflow and volume changes before and after medication administration662$31$42
Test to examine how well the lungs exchange gases662$43$70
Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month277$109$140
Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month263$58$75
Advance care planning consultation, first 30 min247$76$92
New patient office visit (45-59 min)165$122$184
Annual wellness visit, follow-up151$133$140
Sleep study in sleep lab with continuous airway pressure (6 years or older)123$92$135
Sleep study in sleep lab (6 years or older)112$91$130
Sleep study including heart rate, breathing, and sleep time95$32$50
Evaluation of use of breathing device88$14$25
Office visit, established patient, complex (40-54 min)69$141$195
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit60$171$187
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment58$16$25
Electrocardiogram (EKG), 12-lead56$11$20
New patient office visit, complex (60-74 min)50$147$240
Transitional care management services for problem of high complexity43$225$292
Office visit, established patient (20-29 min)37$66$100
Hospital follow-up visit, moderate complexity32$66$85
Drug injection, under skin or into muscle28$11$20
Transitional care management services for problem of at least moderate complexity27$168$220
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional18$19$33
Test to measure oxygen level in blood using ear or finger device continuously overnight12$19$30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$97,086
Total received (2018-2024)
Avg $13,869/year across 7 years
Top 5% in FL for pulmonary disease
52
Companies
633
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85,144 (87.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,941 (12.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29,071
2023
$27,997
2022
$8,203
2021
$1,718
2020
$1,146
2019
$11,964
2018
$16,986

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$60,166
Janssen Pharmaceuticals, Inc
$25,575
Actelion Pharmaceuticals US, Inc.
$1,951
GlaxoSmithKline, LLC.
$973
Genentech USA, Inc.
$750
Grifols USA, LLC
$667
Philips Electronics North America Corporation
$654
Boehringer Ingelheim Pharmaceuticals, Inc.
$649
Insmed, Inc.
$535
Amgen Inc.
$458
Regeneron Healthcare Solutions, Inc.
$453
Mylan Specialty L.P.
$438
Takeda Pharmaceuticals U.S.A., Inc.
$383
United Therapeutics Corporation
$382
Electromed, Inc.
$281
Mallinckrodt Hospital Products Inc.
$266
Mallinckrodt Enterprises LLC
$231
Baxter Healthcare
$213
GENZYME CORPORATION
$174
Mallinckrodt LLC
$153
Medtronic USA, Inc.
$149
Sunovion Pharmaceuticals Inc.
$136
Boston Scientific Corporation
$132
Ipsen Biopharmaceuticals, Inc
$125
Merck Sharp & Dohme Corporation
$125
Novartis Pharmaceuticals Corporation
$85
PFIZER INC.
$84
Paratek Pharmaceuticals, Inc.
$83
JAZZ PHARMACEUTICALS INC.
$66
Melinta Therapeutics, LLC
$65
Merck Sharp & Dohme LLC
$54
Shire North American Group Inc
$53
Bayer HealthCare Pharmaceuticals Inc.
$45
Advanced Respiratory, Inc
$43
INOGEN, INC.
$40
Philips North America LLC
$34
ANI Pharmaceuticals, Inc.
$33
Allergan Inc.
$32
E.R. Squibb & Sons, L.L.C.
$30
Gilead Sciences, Inc.
$29
Novo Nordisk Inc
$28
Amarin Pharma Inc.
$28
CMP Pharma, Inc.
$28
Teva Pharmaceuticals USA, Inc.
$26
Veran Medical Technologies, Inc.
$26
Inspire Medical Systems, Inc.
$26
Celgene Corporation
$25
Vifor Pharma, Inc.
$25
Horizon Therapeutics plc
$25
Resmed Corp
$20
Olympus America Inc.
$19
Astellas Pharma US Inc
$16
Top 3 companies account for 90.3% of total payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · (AK6) Vest Therapy · 120V · 60Hz · ACTHAR · AIR 11 · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Abraxane · Adempas · AirDuo Digihaler · Arikayce · Atorvaliq · Avastin · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · CINQAIR · Cresemba · DUPIXENT · ELIQUIS · EVUSHELD · Esbriet · FASENRA · GLASSIA · HT Bilevel Auto SV · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · KEYTRUDA · LIBTAYO · LONHALA MAGNAIR · Life 2000 Ventilation System · NUCALA · NUZYRA · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ONIVYDE · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · RAYOS · Respiratoriy Care Undiv · SMARTVEST · SOVEREIGN · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · Vascepa · WATCHMAN Access System · WINREVAIR · XARELTO · XOLAIR · Xembify · Xolair · YUPELRI · Yupelri · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for pulmonary disease in FL.

Equivalent to $491 per 100 Medicare services performed
Looking for a pulmonary disease in Stuart?
Compare pulmonary diseases in the Stuart area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
30
Per 100K population
18.7
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
4.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dermarkarian is a clinical cardiology specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (speaking/promotional, top 5%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dermarkarian experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Dermarkarian performed 5,051 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dermarkarian receive payments from pharmaceutical companies?
Yes. Dr. Dermarkarian received a total of $97,086 from 52 companies across 633 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dermarkarian's costs compare to other pulmonary diseases in Stuart?
Dr. Dermarkarian's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dermarkarian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →